Companies / CGS

COGSTATE LTD

ASX:CGSHealth Care Equipment & Services
169.9M shares on issueASX (delayed) · as of 28 July 2026$2.48price · delayed$429.9Mmarket cap · indicative
B
Dilution grade

Options/rights overhang 8% of shares; 2% of shares in the money

Cash runwayno data — not a quarterly (4C/5B) cash filer
Share-count growth (24m)-0.9%
Raise cadence (24m)0 cash raises
Options & rights overhang7.6% of shares
In-the-money supply1.8% of shares
Pending proposed issuesnone

COGSTATE LTD's ordinary share count was 170M as of July 2026, down 0.9% since April 2024. The company did not raise capital in the 24-month window and has no proposed securities issues pending. Options and rights on issue could convert into 13M new shares, equal to 7.6% of the current share count, of which 2% are in the money at the current share price; the nearest expiry is August 2026. The company does not lodge a current quarterly cash report, so no quarterly cash balance or funding-runway figure is disclosed on that basis.

AI-generated summary of this page's cited filings · updated 28 July 2026
Email me when this grade changes
Alerts are coming soon — this opens a pre-filled email that puts you on the list.
7.6%
Max option dilution
1.8%
ITM option dilution
0
Raises · last 12 months
—
Cash cover · not a quarterly filer

Shares on issue — last 2 years

Ordinary shares on issue
Weekly counts from ASX records. Dots mark cash capital raises. Latest count 169.9M per ASX (delayed) (28 July 2026).
169.6M170.8M171.9MDec 24Sept 25July 26

Cash runway

Not a quarterly cash filer. This company does not lodge Appendix 4C/5B quarterly cash reports, so cash runway does not apply.

Issuance timeline

Latest 5 filings (Appendix 2A quoted issues, 3G unquoted, 3H cancellations)

DateFormSecurityTotal on issue afterSource
10 July 20262A · quoted issueCGS : ORDINARY FULLY PAID169.9MAppendix 2A
10 July 20263H · cancellationCGS : ORDINARY FULLY PAID169.9MAppendix 3H
3 June 20263H · cancellationCGS : ORDINARY FULLY PAID169.9MAppendix 3H
9 Apr 20262A · quoted issueCGS : ORDINARY FULLY PAID171.0MAppendix 2A
9 Apr 20263H · cancellationCGS : ORDINARY FULLY PAID171.0MAppendix 3H
Paid plan
Full issuance history
Every quoted and unquoted issue and cancellation on record, plus unquoted securities (Appendix 4.2).
Join the waitlist

Capital raises

No equity raises in the last 24 months.
Paid plan
Full raise history
Issue price, discount, brokers, purpose and tranche detail for every raise on record.
Join the waitlist

Pending proposed issues

No proposed issues (Appendix 3B) currently pending.

Options & convertible securities

7.6%
Total overhang · of current shares
1.8%
In the money · at current price
12.8M
Potential new shares
Aug 2026
Nearest expiry
Paid plan
Per-line options & expiry cliffs
Each option line — code, strike, expiry, quantity and ITM value — plus the expiry-cliff chart.
Join the waitlist

Director dealings

DateDirectorTypeSharesOptionsValueSource
20 May 2026Kim WennBuy4k—$10k3Y notice
12 Apr 2026Martyn MyerSell10.0M—$21.9M3Y notice
12 Apr 2026Martyn MyerSell1.3M—$2.9M3Y notice
Paid plan
Full dealing history
Every change-of-director's-interest notice on record, with direction and consideration.
Join the waitlist

Ownership

Free account
Top-20 holders & substantial holder notices
Top-20 register snapshot and substantial-holder movements, each linked to its source notice.
Sign up free — coming soon

Latest announcements

10 July 2026Notification of cessation of securities - CGS
10 July 2026Application for quotation of securities - CGS
7 July 2026$PCogstate 4Q26 and FY26 Business Update
3 July 2026Change in substantial shareholding from AEF
9 June 2026Investor Insights - Webinar Materials
3 June 2026Notification of cessation of securities - CGS
31 May 2026Webinar - Unlocking Sustainable Clinical Trials Growth
31 May 2026Update - Notification of buy-back - CGS
27 May 2026Update - Notification of buy-back - CGS
21 May 2026Company Secretary Appointment/Resignation
21 May 2026Change of Director's Interest Notice - KW
18 May 2026Update - Notification of buy-back - CGS
14 May 2026Update - Notification of buy-back - CGS
13 May 2026Update - Notification of buy-back - CGS
12 May 2026Update - Notification of buy-back - CGS
11 May 2026Update - Notification of buy-back - CGS
7 May 2026Initial Director's Interest Notice - DI
3 May 2026Update - Notification of buy-back - CGS
23 Apr 2026Update - Notification of buy-back - CGS
23 Apr 2026Appointment of Non-Executive Director

Headlines link to the source PDFs on the ASX announcements platform. Data as of 28 July 2026.